Aptus Capital Advisors’s Eastman Chemical EMN Stock Holding History

Aptus Capital Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,109	Closed	-$239K	–	929
2023 Q3	$239K	Buy	+3,109	New	+$258K	0.01%	521

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aptus Capital Advisors's EMN Position: Q4 2023 in Review

Aptus Capital Advisors sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 3,109 shares — an estimated $239K sold.

Aptus Capital Advisors first reported a position in EMN in Q3 2023 and held it in 1 quarter. The position peaked at $239K in Q3 2023. 711 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

Aptus Capital Advisors reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
Aptus Capital Advisors sold 3,109 Eastman Chemical shares in Q4 2023, an estimated $239K.
Aptus Capital Advisors first reported a position in Eastman Chemical in Q3 2023 and held it in 1 quarter.
Aptus Capital Advisors's Eastman Chemical position peaked at $239K in Q3 2023.
711 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Aptus Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.